Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
07/2003
07/01/2003US6586220 Isolated DNA from Bacillus, encoding the enzymes
07/01/2003US6586217 Mammalian selenophosphate synthetase
07/01/2003US6586216 Modification of enzyme by substitution with non-native amino acids to reduce inhibition by purine nucleotide end products
07/01/2003US6586215 Polypeptides having peroxidase activity and nucleic acids encoding same
07/01/2003US6586214 Eliminating the intracellular activity of the enzyme through mutagenesis; used to increase the fermentative production of nucleotides, vitamins and amino acids, especially L-lysine
07/01/2003US6586209 Xylanase production
07/01/2003US6586207 Host cell is a methionine auxotroph; methionine-tRNA synthetase overexpressed in presence of analogues and absence of methionine; protein is modified dihydrofolate reductase
07/01/2003US6586202 Isoprenoid production
07/01/2003US6586197 Methods and materials for identifying novel pesticide agents
07/01/2003US6586184 Rearranging target nucleotide sequences; obtain cells, transfor with nucleotide sequences, detecting nucleotide sequences adjustment in prokaryotic cell
07/01/2003US6586182 Selecting amino acid sequence variations based on computer modeling; polynucleotides comprising subsequences of nucleic acids encoding the amino acid variations; reassembling into nucleotide sequences encoding mutagenized polypeptides
07/01/2003US6586173 Antibodies; protecting animals from diseases caused by filariids; fluorescent or colorimetric tagged enzyme substrate
07/01/2003US6586015 Use of Phyllanthus for treating chronic inflammatory and fibrotic processes
07/01/2003US6585974 Preventives for hepatopathy
07/01/2003US6585971 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
07/01/2003US6585954 Method for searching steroid sulfatase inhibitors
07/01/2003CA2168037C Transformation systems for the yeast candida utilis and the expression of heterologous genes therewith
07/01/2003CA2122338C Novel human cdc25 genes, encoded products and uses therefor
07/01/2003CA2066387C Viral products
06/2003
06/26/2003WO2003052374A2 Methods for identifying racemases
06/26/2003WO2003052201A1 Novel method for the chlorine-free enzymatic bleaching of high-quality pulps obtained from herbaceous or shrub plants
06/26/2003WO2003052120A2 Dual inhibition of sister chromatide separation at metaphase
06/26/2003WO2003052118A2 Bgl4 beta-glucosidase and nucleic acids encoding the same
06/26/2003WO2003052105A1 Cellulase preparations containing reducing agent and method of processing fiber
06/26/2003WO2003052104A1 A reporter gene
06/26/2003WO2003052103A1 Membrane-associated glutathione-nonspecific prostaglandin e synthase
06/26/2003WO2003052093A1 Regulation of human tetrahydrofolate dehydrogenase/cyclohydrolase
06/26/2003WO2003052092A2 Method for the inactivation of amylase in the presence of protease
06/26/2003WO2003052091A1 Growth factor modified protein matrices for tissue engineering
06/26/2003WO2003052090A1 Phospholipid:diacylglycerol acyltransferases
06/26/2003WO2003052089A1 Disruption of the glutathione s-transferase-omega-1 gene
06/26/2003WO2003052088A2 Regulation of human sialyltransferase
06/26/2003WO2003052087A2 Regulation of human short chain dehydrogenase/-reductase
06/26/2003WO2003052082A2 Fusion partner cells and uses thereof
06/26/2003WO2003052075A2 Enzymes
06/26/2003WO2003052063A2 Simplified eukaryotic nitrate reductase
06/26/2003WO2003052061A2 Novel human proteins, polynucleotides encoding them and methods of using the same
06/26/2003WO2003052059A2 Recombinant bovine thrombin
06/26/2003WO2003052057A2 Egvi endoglucanase and nucleic acids encoding the same
06/26/2003WO2003052056A2 Egviii endoglucanase and nucleic acids encoding the same
06/26/2003WO2003052055A2 Egvii endoglucanase and nucleic acids encoding the same
06/26/2003WO2003052054A2 Bgl5 beta-glucosidase and nucleic acids encoding the same
06/26/2003WO2003052050A2 P450 enzymes, nucleic acids encoding them and methods of making and using them
06/26/2003WO2003051916A2 Crystal structure of nh3-dependent dad+ synthetase from streptococcus pneumoniae
06/26/2003WO2003051914A2 Ides, an igg-degrading enzyme of streptococcus pyogenes
06/26/2003WO2003051908A1 Method for renaturating proteins
06/26/2003WO2003035678A3 Sperm factor sequences
06/26/2003WO2003020005A3 Lp mammalian proteins; related reagents
06/26/2003WO2003004636A3 Expression vectors encoding bacteriophage signal peptides
06/26/2003WO2003000721A3 Mycobacterial antigens expressed under low oxygen tension
06/26/2003WO2002078610A3 Pak2: modulators of lymphocyte activation
06/26/2003WO2002066643A3 Proteins, polynucleotides encoding them and methods of using the same
06/26/2003WO2002064766A3 Bax-responsive genes for drug target identification in yeast and fungi
06/26/2003WO2002062977A3 Human phospholipase b-like polypeptide and uses thereof
06/26/2003WO2002048332A3 Recombinant phytases and uses thereof
06/26/2003WO2002046385A3 Enzymes
06/26/2003WO2002042418A3 3-hydroxypropionic acid and other organic compounds
06/26/2003WO2002016944A3 Synthetic nucleic acid molecule compositions and methods of preparation
06/26/2003WO2002016597A3 Lipid metabolism enzymes
06/26/2003US20030121073 Use of acetoacetyl-CoA thiolase for identifying new fungicidally active substances
06/26/2003US20030121072 Plant histidinol-phosphate aminotransferase homologs
06/26/2003US20030121071 Sulfonylurea-tolerant sunflower plants
06/26/2003US20030121061 Autoimmune diseases, antiinflamamtory agents, central nervous system disorders, vision defects, anticancer agenst
06/26/2003US20030120097 Method for purifying marine mammal oil enriched in omega 3 fatty acids and compositions comprising same
06/26/2003US20030120086 Such as free acids of mevastatin formed via crystallization with tertiary butylamine; antihypercholesterolemic agents
06/26/2003US20030120053 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030120052 Human genetic engineering; cancer diagnosis; hybrid nucleic acid
06/26/2003US20030119887 Lactacystin analogs
06/26/2003US20030119874 Method for enhancing mutant enzyme activity in gaucher disease
06/26/2003US20030119777 Oligoribonucleotides and ribonucleases for cleaving RNA
06/26/2003US20030119748 Use for treatment of inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury.
06/26/2003US20030119729 Promoting survival of substantia nigra neuronal cells by contacting with a trophic amount of a ptc therapeutic; mimics hedgehog-mediated patched signal transduction; treating or preventing Parkinson's Disease
06/26/2003US20030119727 FVIIa antagonists
06/26/2003US20030119690 Multiply-substituted protease variants
06/26/2003US20030119169 Isolated polypeptides; controlling apoptosis
06/26/2003US20030119168 Diagnosis of anticancer agents using nucleic acids
06/26/2003US20030119167 Cellulase preparation comprising an endoglucanase enzyme
06/26/2003US20030119166 Genetic engineered protein
06/26/2003US20030119164 Lysophospholipase
06/26/2003US20030119162 Calibration of signal transduction
06/26/2003US20030119161 32132, a novel fucosyltransferase family member and uses therefor
06/26/2003US20030119160 Drug design, screening; computer analyzing
06/26/2003US20030119155 Culturing a microorganism in which a methanol dehydrogenase gene is used to enhance utilization of methanol and activity of hexulose phosphate synthase and phosphohexuloisomerase; biosynthesis of amino acids
06/26/2003US20030119154 Process for the preparation of L-amino acids using a gene encoding 6-phosphogluconate dehydrogenase
06/26/2003US20030119153 Biosynthesis using enterobacter or serratia which increase enzyme activity; citrate synthase, phosphoenolpyruvate carboxylase and glutamate dehydrogenase
06/26/2003US20030119146 Novel nucleic acids and polypeptides which resemble Rho and which interact with cell signalling pathways and proteins
06/26/2003US20030119145 Amino acid substitutions which result in reduced hydrophobicity; use in oxidizing the terminal methyl group of a substrate to a carboxylic acid
06/26/2003US20030119142 Of given sequence; proteins used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors
06/26/2003US20030119141 Of given sequence; proteins used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors
06/26/2003US20030119140 Of given sequence; proteins used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors
06/26/2003US20030119139 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119138 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119137 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119136 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119133 Of given sequence; proteins used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors
06/26/2003US20030119132 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119131 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119130 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119129 Of given sequence; proteins used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors
06/26/2003US20030119126 Of given sequence; proteins used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors